KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Moderna (MRNA) Exchange Rate Effect (2024 - 2025)

Moderna (MRNA) has disclosed Exchange Rate Effect for 2 consecutive years, with $1.0 million as the latest value for Q3 2025.

  • Quarterly Exchange Rate Effect changed 0.0% to $1.0 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $1.0 million through Dec 2025, changed N/A year-over-year, with the annual reading at $2.0 million for FY2025, N/A changed from the prior year.
  • Exchange Rate Effect for Q3 2025 was $1.0 million at Moderna, up from -$1.0 million in the prior quarter.
  • The five-year high for Exchange Rate Effect was $1.0 million in Q3 2024, with the low at -$1.0 million in Q4 2024.